ZY: Conceptualization, Funding acquisition, Investigation, Writing review & editing
Well discuss this in more detail later
Molecular Weight 3297.6 g/mol Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3 pathway Author links open overlay panelMohamed A Sadek, Esraa A Kandil, Nesrine S El Sayed, Helmy M Sayed, Mostafa A Rabie The Physiology of Glucagon-like Peptide 1 | Physiological Reviews. [Online]
Bottom line: While side effects like dizziness and nausea can occur, they are often temporary and can be managed with consistent hydration and slow physical transitions
What does research say about tracking side effects
For example: On type 2 diabetes Published in Frontiers in Endocrinology , a 2026 case report by Pendulum researchers describes treatment for a 52-year-old man with a medical history of hypertension and type 2 diabetes mellitus